Physician profile
Daniel B Popowitz
NPI 1942599741
$16,730.78
in general payments reported to CMS, 2019-2025
29 companies · $1,999 in 2025
The $1,999 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $4,895 · 2021: $6,435 · 2022: $1,848 · 2023: $341 · 2024: $334 · 2025: $1,999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $1,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,173.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $5,997.30 | 2020-2023 | |
| Crossroads Extremity Systems, LLC | $3,250.00 | 2021 | |
| Royal Biologics, INC. | $1,517.23 | 2020-2025 | Fibrinet |
| Arthrex, INC. | $1,379.84 | 2019-2021 | |
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $736.16 | 2019-2022 | |
| Stryker Corporation | $717.45 | 2019-2025 | Infinity, Citrefix, Infinity Adaptis |
| Seapearl East, INC | $548.89 | 2021-2022 | |
| Treace Medical Concepts, INC. | $286.67 | 2024-2025 | |
| Si-Bone, INC. | $231.75 | 2019-2020 | |
| Paragon 28, INC. | $142.13 | 2021-2024 | Phantom Fibula Nail |
| Orthofix Medical, INC. | $135.70 | 2019-2022 | |
| In2bones USA, LLC | $98.41 | 2019 | |
| Integra Lifesciences Corporation | $96.89 | 2019 | |
| Amgen INC. | $62.63 | 2024-2025 | Krystexxa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $60.12 | 2023-2025 | Bone Anchors With Arthroscopic Delivery System, Ultrabutton, Acufex |
| Depuy Synthes Sales INC. | $50.52 | 2021-2025 | Motoband |
| Davol INC. | $41.94 | 2022 | |
| Abbvie INC. | $33.48 | 2022 | |
| Medtronic, INC. | $30.30 | 2023 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $22.37 | 2025 | |
| Nevro Corp. | $16.37 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $16.36 | 2021 | |
| Abbott Laboratories | $15.36 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.37 | 2022 | |
| Theragen, INC. | $11.70 | 2022 | |
| Advanced Oxygen Therapy INC. | $2.34 | 2023 | Topical Oxygen Chamber For Extremities |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$300,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Popowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.